UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

(Amendment No.     )*

 

 

Trans-India Acquisition Corporation

---

(Name of Issuer)

Common Stock, par value $0.0001 per share

---

(Title of Class of Securities)

 

893237107

(CUSIP Number)

February 14, 2007

---

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

x Rule 13d-1(c)

¨ Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 

Page 1 of 5 pages

---

CUSIP No. 893237107

 

1.		Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only).
		Sarath Naru
2.		Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)  ¨
		(b)  ¨
3.		SEC Use Only
4.		Citizenship or Place of Organization
		India

Number of Shares Beneficially by Owned by Each Reporting Person With:		5.    Sole Voting Power
		0
		6.    Shared Voting Power
		813,331
		7.    Sole Dispositive Power
		0
		8.    Shared Dispositive Power
		813,331

9.		Aggregate Amount Beneficially Owned by Each Reporting Person
		813,331
10.		Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)		¨
11.		Percent of Class Represented by Amount in Row (9)
		5.7%
12.		Type of Reporting Person (See Instructions)
		IN

 

Page 2 of 5 pages

---

Item 1.

(a)

Name of Issuer

Trans-India Acquisition Corporation

(b)

Address of Issuer’s Principal Executive Offices

300 South Wacker Drive, Suite 1000 Chicago, IL 60606

Item 2.

(a)

Name of Person Filing

Sarath Naru

(b)

Address of Principal Business Office or, if none, Residence

20B, ASCI College Park Road No. 3, Banjara Hills, Hyderabad, 500034, India

(c)

Citizenship

India

(d)

Title of Class of Securities

Common Stock, par value $0.0001 (the “Common Stock”)

(e)

CUSIP Number

893237107

Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

¨

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b)

¨

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c)

¨

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d)

¨

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).

(e)

¨

An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

(f)

¨

An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

(g)

¨

A parent holding company or control person in accordance with §240.13d-1(b)(ii)(G);

(h)

¨

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

¨

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

¨

Group, in accordance with §240.13d-1(b)(1)(ii)(J).

 

Page 3 of 5 pages

---

Item 4.		Ownership.
		(a)		Sarath Naru beneficially owns 831,331 shares of the Common Stock, which includes 813,331 shares of the Common Stock held by Marillion Pharmaceuticals India Pvt. Ltd. Mr. Naru is an officer of Marillion Pharmaceuticals India Pvt. Ltd. and has an indirect pecuniary interest in the securities held by such entity. Mr. Naru disclaims beneficial ownership of the 813,331 shares of the Common Stock held by Marillion Pharmaceuticals India Pvt. Ltd.
		(b)		Percent of class:
				5.7%
		(c)		Number of shares as to which the person has:
				(i)		Sole power to vote or to direct the vote
						0
				(ii)		Shared power to vote or to direct the vote
						813,331
				(iii)		Sole power to dispose or to direct the disposition of
						0
				(iv)		Shared power to dispose or to direct the disposition of
						813,331
Item 5.		Ownership of Five Percent or Less of a Class
		Inapplicable.
Item 6.		Ownership of More than Five Percent on Behalf of Another Person.
		Inapplicable.
Item 7.		Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
		Inapplicable.
Item 8.		Identification and Classification of Members of the Group
		Inapplicable.
Item 9.		Notice of Dissolution of Group
		Inapplicable.
Item 10.		Certification
		By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

Page 4 of 5 pages

---

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 26, 2007

 

 

Page 5 of 5 pages